
Mukka Proteins Q1 FY27 Results: Revenue Rs 489 Cr, PAT Rs 19 Cr and Key Highlights
Mukka Proteins Q1 FY27: Revenue Rs 489 Cr (+186.73% YoY). PAT Rs 19 Cr (+861.94% YoY). Results August 12, 2026. CMP Rs 27.18.
Updated: 13 Aug 2026 • 3:30 pm
Posted by:

Quick Answer
Mukka Proteins reported a 862% jump in net profit to Rs 19 crore in Q1 FY27, compared with Rs 2 crore in the same quarter last year. Revenue climbed 187% to Rs 489 crore during the June 2026 quarter, with gross profit expanding significantly to Rs 43 crore. The Mukka Proteins Q1 FY27 results reflect solid operating momentum within the Aquaculture and Fish Products sector.
Mukka Proteins Q1 FY27 results were declared on August 12, 2026, with the aquaculture and fish products company reporting a net profit (PAT) of Rs 19 crore, up 861.94% from Rs 2 crore in Q1 FY26. The figures are on a consolidated basis for the quarter ended June 30, 2026.
The June 2026 quarter saw sharp growth in Mukka Proteins's revenue, which climbed 187% year on year to Rs 489 crore. Gross profit for the period stood at Rs 43 crore, up from Rs 11 crore a year earlier.
Click Here – Get Free Investment Predictions
Mukka Proteins Q1 FY27 Financial Highlights
The table below breaks down the key financial figures from the Mukka Proteins Q1 FY27 results against Q1 FY26.
| Metric | Q1 FY27 (Jun 2026) | Q1 FY26 (Jun 2025) | YoY Change |
|---|---|---|---|
| Revenue from Operations (Rs Cr) | Rs 489 Cr | Rs 170 Cr | +186.73% |
| Gross Profit (Rs Cr) | Rs 43 Cr | Rs 11 Cr | +282.40% |
| Net Profit / (Loss) – PAT (Rs Cr) | Rs 19 Cr | Rs 2 Cr | +861.94% |
Mukka Proteins Q1 FY27 Results Performance Analysis
Use the Univest Screener to Track Live Fundamentals of Indian Stocks
The Mukka Proteins Q1 FY27 results show revenue growth of 186.73% year on year to Rs 489 crore. Gross profit improved to Rs 43 crore from Rs 11 crore in Q1 FY26.
Net profit in the June 2026 quarter stood at Rs 19 crore, up 861.94% from Rs 2 crore in Q1 FY26. Investors should verify all figures against the company's official filings on BSE and NSE.
Key Business Factors in Mukka Proteins Q1 FY27
1. Revenue Growth Expanded the Top Line
186.73% revenue growth year on year reflects strengthening demand in the Aquaculture and Fish Products segment. The June 2026 quarter benefited from higher volumes and improved pricing.
2. Gross Profit Trend
Gross profit rose to Rs 43 crore from Rs 11 crore in Q1 FY26. Better raw material costs and pricing power supported the improvement.
3. Net Profit Rose Quarter on Quarter
Net profit came in at Rs 19 crore, up 861.94% from Rs 2 crore in Q1 FY26. The double-digit profit growth signals solid earnings quality in the current business cycle.
Dividend Details
No dividend has been announced along with the Mukka Proteins Q1 FY27 results for the quarter ended June 2026. Investors can check future dividend updates on BSE and NSE.
Mukka Proteins FY27 Outlook After Q1 Results
The June 2026 quarter results lay a reasonable foundation for FY27. Revenue growth of 186.73% combined with a net profit (PAT) of Rs 19 crore shows the company is firing on most cylinders. Investors tracking the Mukka Proteins Q1 FY27 results should watch for management commentary on demand trends in Aquaculture and Fish Products, raw material cost outlook, and any capex or expansion plans that could shape FY27 earnings.
Mukka Proteins Stock Performance
Download the Univest iOS App or Univest Android App to track Mukka Proteins share price and upcoming results.
Mukka Proteins shares were trading at Rs 27.18 on August 12, 2026, the day the Aquaculture and Fish Products company announced its Q1 FY27 results. Post-results price action will depend on how the market interprets the revenue and profit trajectory. Always check the latest price on NSE and BSE before making any investment decision.
Key Risks After Mukka Proteins Q1 FY27 Results
1. Demand Slowdown in Aquaculture and Fish Products
A pullback in Aquaculture and Fish Products demand could weigh on revenue growth and make it harder to sustain the profitability levels seen in Q1 FY27.
2. Input Cost and Margin Pressure
Rising raw material costs or an unfavourable sales mix could squeeze gross margins and limit net profit improvement through the rest of FY27.
3. Macro and Regulatory Headwinds
Broader factors such as interest rate movements, currency volatility, and sector-specific regulatory changes remain risks to watch for the remainder of FY27.
Conclusion
The Mukka Proteins Q1 FY27 results show revenue of Rs 489 crore and a net profit (PAT) of Rs 19 crore, up 861.94% from Rs 2 crore in Q1 FY26. The performance reflects the company's current standing in the Aquaculture and Fish Products space. Investors should go through the detailed financial statements on BSE and NSE and seek advice from a SEBI-registered advisor before investing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Mukka Proteins Q1 FY27 Results
When were the Mukka Proteins Q1 FY27 results announced?
Ans. The Mukka Proteins Q1 FY27 results were announced on August 12, 2026. The consolidated financials cover the quarter ended June 30, 2026, and were filed with the BSE and NSE on the same date.
What was the net profit in the Mukka Proteins Q1 FY27 results?
Ans. Net profit (PAT) stood at Rs 19 crore in Q1 FY27, up 861.94% from Rs 2 crore in Q1 FY26.
What was the revenue in the Mukka Proteins Q1 FY27 results?
Ans. Revenue for the June 2026 quarter grew 186.73% year on year to Rs 489 crore from Rs 170 crore in Q1 FY26.
Did Mukka Proteins declare a dividend with Q1 FY27 results?
Ans. No dividend has been declared alongside the Mukka Proteins Q1 FY27 results for the June 2026 quarter. Any future dividend announcements will be available on the BSE and NSE portals.
What is the FY27 outlook for Mukka Proteins after Q1 results?
Ans. The June 2026 quarterly performance signals a positive trajectory for FY27. Key factors to watch include demand trends in the Aquaculture and Fish Products sector, margin performance, and management guidance for the year.
Is Mukka Proteins a good stock to buy after Q1 FY27 results?
Ans. The Q1 FY27 results of Mukka Proteins provide insight into the company's financial health, but investment decisions should never be based on one quarter alone. This article is for educational purposes and does not constitute investment advice. Please consult a SEBI-registered advisor before making any investment decision.
Recent Articles

Mishra Dhatu Nigam Q1 FY27 Results: Revenue Rs 239 Cr, PAT Rs 16 Cr and Key Highlights
13 August 2026

Marksans Pharma Q1 FY27 Results: Revenue Rs 840 Cr, PAT Rs 159 Cr and Key Highlights
13 August 2026

Titagarh Rail Systems Q1 FY27 Results: Revenue Rs 765 Cr, PAT Rs 53 Cr and Key Highlights
13 August 2026

Valiant Communications Q1 FY27 Results: Revenue Rs 25 Cr, PAT Rs 7 Cr and Key Highlights
13 August 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Mishra Dhatu Nigam Q1 FY27 Results: Revenue Rs 239 Cr, PAT Rs 16 Cr and Key Highlights
Marksans Pharma Q1 FY27 Results: Revenue Rs 840 Cr, PAT Rs 159 Cr and Key Highlights
Titagarh Rail Systems Q1 FY27 Results: Revenue Rs 765 Cr, PAT Rs 53 Cr and Key Highlights
Valiant Communications Q1 FY27 Results: Revenue Rs 25 Cr, PAT Rs 7 Cr and Key Highlights
Black Box Q1 FY27 Results: Revenue Rs 1,718 Cr, PAT Rs 55 Cr and Key Highlights
Popular this week
Saraswati Commercial Q1 FY27 Results: Revenue Rs 75 Cr, PAT Rs 63 Cr and Key Highlights

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





